CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 1 shares at $6.00 ($6)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,744 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,250 shares (option exercise)
- 4 Shares withheld for taxes President and COO gave up 4,148 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 2,956 shares (to pay taxes)
- 4 Exercise or conversion Chief Financial Officer acquired 10,800 shares (option exercise)
- 4 Exercise or conversion CEO acquired 37,533 shares (option exercise)
Page 8 of 23 · 459 filings